Nanosystems offer unique capabilities, enabling researchers to design precise, versatile delivery systems that address key challenges in rare diseases.
- Closing The Adherence Gap: The Connected Health Era
- Delivery Strategy For Next-Gen Cardiac Gene Therapies
- The Future Of Kidney Disease Therapeutics: Bringing Nanomedicine To Nephrology
- Injecting Cancer Killers: Intratumoral Therapy For Solid Tumors
- The Advantages Of Antibodies Over Ligands In The Alpha Emitter Era
- GenAI: The Muscle Behind Strong Regulatory Intelligence For Combination Products
- Regulatory Precedents For Drug Delivery: Uncovering Clues To Successful Submissions
- Microneedle Delivery Of Telomerase Protects Skin From Radiation-Induced DNA Damage
ON-DEMAND WEBINARS
The simultaneous spray drying of multiple ingredients is a powerful technique for making inhaled products with multiple actives. Examine how novel techniques can make these products a reality.
Learn more about defining the spray drying process with an emphasis on specific enhancements to accommodate scale-up to commercial scale equipment of challenging applications or molecules.
What technical issues need to be addressed if an API is to be successfully micronized? Explore a robust process development strategy that ensures all attributes critical for quality are maintained.
A review of the draft guidance and importance of component selection as it relates to establishing a risk-based approach and the role of the NovaPure product line in component selection.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1284529278-syringe-pre-filled-PFS]( "New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory Pathway")
New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory PathwayDiscover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and stakeholder engagement is essential.
-
![iStock-1205850790-oral-solid-dose-OSD-tablet-capsule-pill]( "Understanding Of Amorphous Solid Dispersions & Their Downstream Development")
Understanding Of Amorphous Solid Dispersions & Their Downstream DevelopmentUnderstanding the properties of ASDs and their relationship to the downstream product scale up, stability, and in-vivo performance is critical to successfully utilize them for drug delivery of insoluble drugs.
-
![GettyImages-597935610 cell and gene]( "Delivering The Promise Of Gene Therapy")
Delivering The Promise Of Gene TherapyGene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
-
![GettyImages-1087218944 Scientists In Sterile Suits Working With Computers In The Laboratory]( "Meet Regulation Requirements With RTU Vials And Cartridges")
Meet Regulation Requirements With RTU Vials And CartridgesSterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.
-
![INCOG]( "Key Financial Considerations For Phase II Clinical Injectable Drug Manufacturing")
Key Financial Considerations For Phase II Clinical Injectable Drug ManufacturingThis article highlights the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.
-
![GettyImages-1328085510-patient-child-doctor-pediatric]( "Combining Patient Centricity And Commercial Viability In Pediatric Product Development")
Combining Patient Centricity And Commercial Viability In Pediatric Product DevelopmentMedication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.
-
![GettyImages-1371993517-syringe-vial-mask-vaccine-inject]( "Why It Is Never Too Early To Consider Tungsten Interactions")
Why It Is Never Too Early To Consider Tungsten InteractionsA key challenge to sensitive biotechnological or biologic drugs, especially proteins, is the potential presence of tungsten and tungsten oxides from the syringe forming process.
-
![Old-Elderly-Cane]( "Designing Delivery Devices For Older Adults With Cognitive Impairment")
Designing Delivery Devices For Older Adults With Cognitive ImpairmentLeverage our insights to improve your human factors studies and ensure the effective inclusion of older adults with mild cognitive impairment.
-
![Multicolored pills-GettyImages-1370358685]( "Solid Form Strategies For Increasing Oral Bioavailability")
Solid Form Strategies For Increasing Oral BioavailabilityOptimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.
-
![gettyimages-1253545551-170667a (1)]( "Wet Milling Vs. Dry Milling In The Pharmaceutical Industry")
Wet Milling Vs. Dry Milling In The Pharmaceutical IndustryRead about the considerations necessary for choosing between wet milling and dry milling for a specific active pharmaceutical ingredient.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![111Delivered-_by-_DeGrazio_Logo_Color_1]( "4 Opportunities For Advancing Drug Delivery")
4 Opportunities For Advancing Drug DeliveryIn this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
